Luis Felipe Ensina
Federal University of São Paulo
What is this?
Publications 95
#1Luis Felipe Ensina (UNIFESP: Federal University of São Paulo)H-Index: 11
Last. RC Agondi
view all 11 authors...
#1Luis Felipe EnsinaH-Index: 11
Last. L. Karla ArrudaH-Index: 22
view all 10 authors...
#2Werner Aberer (Medical University of Graz)H-Index: 51
#3Rosana Câmara Agondi (USP: University of São Paulo)H-Index: 12
Last. Emel Aygören-PürsünH-Index: 21
view all 134 authors...
BACKGROUND AND OBJECTIVE: Severe cutaneous adverse reactions to drugs (SCARs), have a high morbidity, mortality and present sequelae. Objective: To characterize patients with SCARs in eight health care institutions in Latin America. METHODS: Cross-sectional, descriptive, multicenter, Latin American study of patients diagnosed with SCARs, between January 2009 and December 2018. The analysis was made from a database in BD Clinic. RESULTS: Seventy cases were reported. Forty-two (60%) were women. Th...
This paper aimed to summarize and review the known data on anaphylaxis and hypersensitivity reactions to vitamins. Vitamins A, C, D, and E seem to be extremely safe compounds, with few or no related case of anaphylaxis to them. Vitamin B1 is considered the most allergenic vitamin. Immediate reactions are unusual, but urticaria and anaphylaxis to thiamine intravenous administration have been described. Vitamin B12 hypersensitivity is also infrequent. Reactions occur mostly in patients receiving l...
#1N.P.M. Rubini (UNIRIO: Universidade Federal do Estado do Rio de Janeiro)
#2Luis Felipe Ensina (UNIFESP: Federal University of São Paulo)H-Index: 11
Last. Dirceu Solé (UNIFESP: Federal University of São Paulo)H-Index: 36
view all 5 authors...
Abstract Introduction Chronic spontaneous urticaria (CSU) affects approximately 1% of the population, affecting both children and adults. Omalizumab (Oma) is a therapeutic option for patients with refractory forms of CSU. Objectives To determine the effectiveness and safety of Oma in the treatment of CSU. Methods Systematic review (Cochrane Collaboration methodology) of randomized clinical trials comparing Oma to placebo in refractory CSU treatment. The search is based on MEDLINE; EMBASE, Centra...
#1Jorge Sánchez (UdeA: University of Antioquia)H-Index: 12
view all 12 authors...
La Sociedad Latinoamericana de Asma, Alergia e Inmunologia (SLAAI), realizo una busqueda sistematica en la base de datos de Medline y LILAC para obtener articulos relacionados con 10 preguntas actuales sobre la dermatitis: ?Como deberiamos clasificar la dermatitis atopica en la practica clinica? ?Se puede prevenir la dermatitis atopica? ?Podemos predecir la duracion de la dermatitis atopica? ?Influye la microbiota cutanea en el control de la dermatitis atopica? ?Es util el uso de probioticos en ...